BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27819189)

  • 21. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes.
    Wang M; Jiang W; Zhou J; Xue X; Yin C
    Pharm Biol; 2020 Dec; 58(1):1064-1069. PubMed ID: 33103940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
    Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
    Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Ji X; Ding B; Wu X; Liu F; Yang F
    Xenobiotica; 2021 Mar; 51(3):262-267. PubMed ID: 33115303
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Zhao H; Xue S; Meng Q; Zhou C
    Xenobiotica; 2021 Sep; 51(9):977-982. PubMed ID: 34176447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
    Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.
    Jin C; He X; Zhang F; He L; Chen J; Wang L; An L; Fan Y
    Xenobiotica; 2015; 45(7):571-7. PubMed ID: 25811791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
    Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
    Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro study on the effect of cornin on the activity of cytochrome P450 enzymes.
    Zhang Q; Qu Z; Zhou Y; Zhou J; Yang J; Li S; Xu Q; Zhou X
    BMC Complement Med Ther; 2021 May; 21(1):138. PubMed ID: 33966625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes.
    Wang H; Xia B; Lin M; Wang Y; Sun B; Li Y
    Pharm Biol; 2020 Dec; 58(1):1150-1155. PubMed ID: 33327821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
    Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
    Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evaluation of the inhibition potential of echinacoside on human cytochrome P450 isozymes.
    Wu Y; Qiao A; Lin S; Chen L
    BMC Complement Med Ther; 2022 Feb; 22(1):46. PubMed ID: 35180866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.
    Habenschus MD; Moreira FL; Lopes NP; de Oliveira ARM
    Planta Med; 2017 May; 83(8):727-736. PubMed ID: 28073119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the
    Giri P; Gupta L; Singh S; Patel N; Srinivas NR; Srivastva BK; Desai RC; Patel PR
    Xenobiotica; 2019 Oct; 49(10):1164-1172. PubMed ID: 30488748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereoselective interaction between tetrahydropalmatine enantiomers and CYP enzymes in human liver microsomes.
    Sun SY; Wang YQ; Li LP; Wang L; Zeng S; Zhou H; Jiang HD
    Chirality; 2013 Jan; 25(1):43-7. PubMed ID: 23001793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.
    Rastogi H; Jana S
    Phytother Res; 2014 Dec; 28(12):1873-8. PubMed ID: 25196644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agrimoniin inhibits the activity of CYP1A2, 2D6, and 3A4 in human liver microsomes.
    Zhou Y; Xian Q; Wei H; Zhou J; Li S; Yang J; Zhou X; Li Y
    Xenobiotica; 2021 Dec; 51(12):1360-1365. PubMed ID: 34806927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.